Literature DB >> 28255675

Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor-containing afferents in the noradrenergic nucleus locus coeruleus: implications for the cognitive limb of the stress response.

Ryan R Wyrofsky1, Beverly A S Reyes2, Elisabeth J Van Bockstaele2.   

Abstract

The noradrenergic system has been shown to play a key role in the regulation of stress responses, arousal, mood, and emotional states. Corticotropin-releasing factor (CRF) is a primary mediator of stress-induced activation of noradrenergic neurons in the nucleus locus coeruleus (LC). The endocannabinoid (eCB) system also plays a key role in modulating stress responses, acting as an "anti-stress" neuro-mediator. In the present study, we investigated the cellular sites for interactions between the cannabinoid receptor type 1 (CB1r) and CRF in the LC. Immunofluorescence and high-resolution immunoelectron microscopy showed co-localization of CB1r and CRF in both the core and peri-LC areas. Semi-quantitative analysis revealed that 44% (208/468) of CRF-containing axon terminals in the core and 35% (104/294) in the peri-LC expressed CB1r, while 18% (85/468) of CRF-containing axon terminals in the core and 6.5% (19/294) in the peri-LC were presynaptic to CB1r-containing dendrites. In the LC core, CB1r + CRF axon terminals were more frequently of the symmetric (inhibitory) type; while in the peri-LC, a majority were of the asymmetric (excitatory) type. Triple label immunofluorescence results supported the ultrastructural analysis indicating that CB1r + CRF axon terminals contained either gamma amino butyric acid or glutamate. Finally, anterograde transport from the central nucleus of the amygdala revealed that CRF-amygdalar afferents projecting to the LC contain CB1r. Taken together, these results indicate that the eCB system is poised to directly modulate stress-integrative heterogeneous CRF afferents in the LC, some of which arise from limbic sources.

Entities:  

Keywords:  Addiction; Arousal; Norepinephrine; Psychiatric disorders

Mesh:

Substances:

Year:  2017        PMID: 28255675      PMCID: PMC8340878          DOI: 10.1007/s00429-017-1381-7

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  121 in total

Review 1.  An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance.

Authors:  Gary Aston-Jones; Jonathan D Cohen
Journal:  Annu Rev Neurosci       Date:  2005       Impact factor: 12.449

2.  Glutamate decarboxylase in inhibitory neurons. A study of the enzyme in Purkinje cell axons and boutons in the cat.

Authors:  F Fonnum; J Storm-Mathisen; F Walberg
Journal:  Brain Res       Date:  1970-06-03       Impact factor: 3.252

3.  Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling.

Authors:  Sachin Patel; Craig T Roelke; David J Rademacher; Cecilia J Hillard
Journal:  Eur J Neurosci       Date:  2005-02       Impact factor: 3.386

4.  Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors.

Authors:  Robert Papay; Robert Gaivin; Archana Jha; Dan F McCune; John C McGrath; Manoj C Rodrigo; Paul C Simpson; Van A Doze; Dianne M Perez
Journal:  J Comp Neurol       Date:  2006-07-10       Impact factor: 3.215

5.  Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain.

Authors:  Attila Tóth; Judit Boczán; Noémi Kedei; Erzsébet Lizanecz; Zsolt Bagi; Zoltán Papp; István Edes; László Csiba; Peter M Blumberg
Journal:  Brain Res Mol Brain Res       Date:  2005-01-22

6.  The endocannabinoid system within the dorsal lateral geniculate nucleus of the vervet monkey.

Authors:  P Javadi; J Bouskila; J-F Bouchard; M Ptito
Journal:  Neuroscience       Date:  2015-01-06       Impact factor: 3.590

7.  Cellular interactions between axon terminals containing endogenous opioid peptides or corticotropin-releasing factor in the rat locus coeruleus and surrounding dorsal pontine tegmentum.

Authors:  S I Tjoumakaris; C Rudoy; J Peoples; R J Valentino; E J Van Bockstaele
Journal:  J Comp Neurol       Date:  2003-11-24       Impact factor: 3.215

Review 8.  The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.

Authors:  E J Van Bockstaele; B A S Reyes; R J Valentino
Journal:  Brain Res       Date:  2009-09-16       Impact factor: 3.252

Review 9.  Endocannabinoid signaling and synaptic function.

Authors:  Pablo E Castillo; Thomas J Younts; Andrés E Chávez; Yuki Hashimotodani
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

10.  Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex.

Authors:  M E Page; V C Oropeza; E J Van Bockstaele
Journal:  Neurosci Lett       Date:  2007-11-09       Impact factor: 3.046

View more
  4 in total

1.  Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus-norepinephrine neurons and corticotropin releasing factor-mediated responses.

Authors:  Ryan R Wyrofsky; Beverly A S Reyes; Daohai Yu; Lynn G Kirby; Elisabeth J Van Bockstaele
Journal:  Eur J Neurosci       Date:  2018-09       Impact factor: 3.386

Review 2.  Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system.

Authors:  Ryan R Wyrofsky; Beverly A S Reyes; Xiao-Yan Zhang; Seema Bhatnagar; Lynn G Kirby; Elisabeth J Van Bockstaele
Journal:  Neurobiol Stress       Date:  2019-05-25

Review 3.  Resilience to stress and social touch.

Authors:  Alexies Dagnino-Subiabre
Journal:  Curr Opin Behav Sci       Date:  2021-09-14

Review 4.  Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer's disease.

Authors:  Ronnie D Shade; Jennifer A Ross; Elisabeth J Van Bockstaele
Journal:  Front Aging Neurosci       Date:  2022-10-04       Impact factor: 5.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.